Indocyanine Green-Assisted Internal Limiting Membrane Peeling in Macular Hole Surgery: A Meta-Analysis

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Wu, Yan ^a,b   Zhu, Wei ^a,b   Xu, Ding ^a   Li, Yan Hong ^a   Ba, Jun ^a   Zhang, Xiao Long ^b   Wang, Fang ^a   Yu, Jing ^a  

^a TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INDOCYANINE GREEN;

ANATOMY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INTERNAL LIMITING MEMBRANE PEELING; META ANALYSIS; POSTOPERATIVE COMPLICATION; RETINA MACULA HOLE; RETINA SURGERY; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ACUITY; VISUAL FIELD DEFECT;

CLINICAL TRIALS AS TOPIC; FOLLOW-UP STUDIES; HUMANS; INDOCYANINE GREEN; OPHTHALMOLOGIC SURGICAL PROCEDURES; PUBLICATION BIAS; RETINAL PERFORATIONS; RETINAL PIGMENT EPITHELIUM; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84868682236     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048405     Document Type: Article

References (65)

1. Tognetto D, Grandin R, Sanguinetti G, Minutola D, Di Nicola M, et al. (2006) Internal limiting membrane removal during macular hole surgery: results of a multicenter retrospective study. Ophthalmology 113: 1401-1410.
2. Kwok AK, Li WW, Pang CP, Lai TY, Yam GH, et al. (2001) Indocyanine green staining and removal of internal limiting membrane in macular hole surgery: histology and outcome. Am J Ophthalmol 132: 178-183.
3. Freeman WR, Azen SP, Kim JW, el-Haig W, Mishell DR 3rd, et al. (1997) Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Results of a multicentered randomized clinical trial. The Vitrectomy for Treatment of Macular Hole Study Group. Arch Ophthalmol 115: 11-21.
4. Da Mata AP, Burk SE, Riemann CD, Rosa RH Jr, Snyder ME, et al. (2001) Indocyanine green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for macular hole repair. Ophthalmology 108: 1187-1192.
5. Kwok AK, Lai TY, Man-Chan W, Woo DC, (2003) Indocyanine green assisted retinal internal limiting membrane removal in stage 3 or 4 macular hole surgery. Br J Ophthalmol 87: 71-74.
6. Fukuda K, Shiraga F, Yamaji H, Nomoto H, Shiragami C, et al. (2011) Morphologic and functional advantages of macular hole surgery with brilliant blue G-assisted internal limiting membrane peeling. Retina 31: 1720-1725.
7. Stanga PE, Lim JI, Hamilton P, (2003) Indocyanine green angiography in chorioretinal diseases: indications and interpretation: an evidence-based update. Ophthalmology 110: 15-21; quiz 22-13.
8. Desmettre T, Devoisselle JM, Mordon S, (2000) Fluorescence properties and metabolic features of indocyanine green (ICG) as related to angiography. Surv Ophthalmol 45: 15-27.
9. Chung CF, Liang CC, Lai JS, Lo ES, Lam DS, (2005) Safety of trypan blue 1% and indocyanine green 0.5% in assisting visualization of anterior capsule during phacoemulsification in mature cataract. J Cataract Refract Surg 31: 938-942.
10. Anijeet DR, Zheng Y, Tey A, Hodson M, Sueke H, et al. (2012) Imaging and evaluation of corneal vascularization using fluorescein and indocyanine green angiography. Invest Ophthalmol Vis Sci 53: 650-658.
11. Engelbrecht NE, Freeman J, Sternberg P Jr, Aaberg TM Sr, Aaberg TM Jr, et al. (2002) Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 133: 89-94.
12. Cullen R, (1998) Macular hole surgery: helpful tips for preoperative planning and postoperative face-down positioning. J Ophthalmic Nurs Technol 17: 179-181.
13. Sippy BD, Engelbrecht NE, Hubbard GB, Moriarty SE, Jiang S, et al. (2001) Indocyanine green effect on cultured human retinal pigment epithelial cells: implication for macular hole surgery. Am J Ophthalmol 132: 433-435.
14. Kanda S, Uemura A, Yamashita T, Kita H, Yamakiri K, et al. (2004) Visual field defects after intravitreous administration of indocyanine green in macular hole surgery. Arch Ophthalmol 122: 1447-1451.
15. Lochhead J, Jones E, Chui D, Lake S, Karia N, et al. (2004) Outcome of ICG-assisted ILM peel in macular hole surgery. Eye (Lond) 18: 804-808.
16. Ando F, Sasano K, Ohba N, Hirose H, Yasui O, (2004) Anatomic and visual outcomes after indocyanine green-assisted peeling of the retinal internal limiting membrane in idiopathic macular hole surgery. Am J Ophthalmol 137: 609-614.
17. Moher D, Liberati A, Tetzlaff J, Altman DG, (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339: b2535.
18. Volk RJ, Wolf AM, (2011) Grading the new US Preventive Services Task Force prostate cancer screening recommendation. JAMA 306: 2715-2716.
19. Downs SH, Black N, (1998) The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 52: 377-384.
20. Stang A, (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25: 603-605.
21. Aziz O, Athanasiou T, Tekkis PP, Purkayastha S, Haddow J, et al. (2006) Laparoscopic versus open appendectomy in children: a meta-analysis. Ann Surg 243: 17-27.
22. Vanner EA, Stewart MW, (2011) Vitrectomy timing for retained lens fragments after surgery for age-related cataracts: a systematic review and meta-analysis. Am J Ophthalmol 152: 345-357 e343.
23. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
24. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
25. Tsuiki E, Fujikawa A, Miyamura N, Yamada K, Mishima K, et al. (2007) Visual field defects after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 143: 704-705.
26. Mavrofrides E, Smiddy WE, Kitchens JW, Salicone A, Feuer W, (2006) Indocyanine green-assisted internal limiting membrane peeling for macular holes: toxicity? Retina 26: 637-644.
27. Brockmann T, Steger C, Westermann M, Nietzsche S, Koenigsdoerffer E, et al. (2011) Ultrastructure of the membrana limitans interna after dye-assisted membrane peeling. Ophthalmologica 226: 228-233.
28. Shukla D, Kalliath J, Neelakantan N, Naresh KB, Ramasamy K, (2011) A comparison of brilliant blue G, trypan blue, and indocyanine green dyes to assist internal limiting membrane peeling during macular hole surgery. Retina 31: 2021-2025.
29. Christensen UC, Kroyer K, Sander B, Larsen M, Henning V, et al. (2009) Value of internal limiting membrane peeling in surgery for idiopathic macular hole stage 2 and 3: a randomised clinical trial. Br J Ophthalmol 93: 1005-1015.
30. Schaal S, Barr CC, (2009) Management of macular holes: a comparison of 1-year outcomes of 3 surgical techniques. Retina 29: 1091-1096.
31. Nakamura Y, Kondo M, Asami T, Terasaki H, (2009) Comparison of macular hole surgery without internal limiting membrane peeling to eyes with internal limiting membrane peeling with and without indocyanine green staining: three-year follow-up. Ophthalmic Res 41: 136-141.
32. Thompson JT, (2007) The effect of internal limiting membrane removal and indocyanine green on the success of macular hole surgery. Trans Am Ophthalmol Soc 105: 198-205; discussion 205-196.
33. Nomoto H, Shiraga F, Yamaji H, Fukuda K, Baba T, et al. (2008) Macular hole surgery with triamcinolone acetonide-assisted internal limiting membrane peeling: one-year results. Retina 28: 427-432.
34. Nagai N, Ishida S, Shinoda K, Imamura Y, Noda K, et al. (2007) Surgical effects and complications of indocyanine green-assisted internal limiting membrane peeling for idiopathic macular hole. Acta Ophthalmol Scand 85: 883-889.
35. Beutel J, Dahmen G, Ziegler A, Hoerauf H, (2007) Internal limiting membrane peeling with indocyanine green or trypan blue in macular hole surgery: a randomized trial. Arch Ophthalmol 125: 326-332.
36. Ferencz M, Somfai GM, Farkas A, Kovacs I, Lesch B, et al. (2006) Functional assessment of the possible toxicity of indocyanine green dye in macular hole surgery. Am J Ophthalmol 142: 765-770.
37. Kumagai K, Furukawa M, Ogino N, Uemura A, Larson E, (2006) Long-term outcomes of internal limiting membrane peeling with and without indocyanine green in macular hole surgery. Retina 26: 613-617.
38. Husson-Danan A, Glacet-Bernard A, Soubrane G, Coscas G, (2006) Clinical evaluation of the use of indocyanine green for peeling the internal limiting membrane in macular hole surgery. Graefes Arch Clin Exp Ophthalmol 244: 291-297.
39. Lee KL, Dean S, Guest S, (2005) A comparison of outcomes after indocyanine green and trypan blue assisted internal limiting membrane peeling during macular hole surgery. Br J Ophthalmol 89: 420-424.
40. Karacorlu M, Ozdemir H, Arf Karacorlu S, (2005) Does intravitreal triamcinolone acetonide-assisted peeling of the internal limiting membrane effect the outcome of macular hole surgery? Graefes Arch Clin Exp Ophthalmol 243: 754-757.
41. Slaughter K, Lee IL, (2004) Macular hole surgery with and without indocyanine green assistance. Eye (Lond) 18: 376-378.
42. Sheidow TG, Blinder KJ, Holekamp N, Joseph D, Shah G, et al. (2003) Outcome results in macular hole surgery: an evaluation of internal limiting membrane peeling with and without indocyanine green. Ophthalmology 110: 1697-1701.
43. Horio N, Horiguchi M, (2004) Effect on visual outcome after macular hole surgery when staining the internal limiting membrane with indocyanine green dye. Arch Ophthalmol 122: 992-996.
44. Gandorfer A, Messmer EM, Ulbig MW, Kampik A, (2001) Indocyanine green selectively stains the internal limiting membrane. Am J Ophthalmol 131: 387-388.
45. Haritoglou C, Gandorfer A, Gass CA, Schaumberger M, Ulbig MW, et al. (2002) Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathologic correlation. Am J Ophthalmol 134: 836-841.
46. Samoocha D, Bruinvels DJ, Elbers NA, Anema JR, van der Beek AJ, (2010) Effectiveness of web-based interventions on patient empowerment: a systematic review and meta-analysis. J Med Internet Res 12: e23.
47. Kwok AK, Lai TY, Yew DT, Li WW, (2003) Internal limiting membrane staining with various concentrations of indocyanine green dye under air in macular surgeries. Am J Ophthalmol 136: 223-230.
48. Rodrigues EB, Meyer CH, (2008) Meta-analysis of chromovitrectomy with indocyanine green in macular hole surgery. Ophthalmologica 222: 123-129.
49. Haritoglou C, Gandorfer A, Gass CA, Kampik A, (2002) Indocyanine green staining and removal of internal limiting membrane in macular hole surgery: histology and outcome. Am J Ophthalmol 133: 587-588; author reply 588.
50. Stanescu-Segall D, Jackson TL, (2009) Vital staining with indocyanine green: a review of the clinical and experimental studies relating to safety. Eye (Lond) 23: 504-518.
51. Haritoglou C, Neubauer AS, Gandorfer A, Thiel M, Kampik A, (2003) Indocyanine green for successful repair of a long-standing macular hole. Am J Ophthalmol 136: 389-391.
52. Meyer CH, Rodrigues EB, Kroll P, (2004) Reduced concentration and incubation of intravitreal indocyanine green can improve the functional outcome in macular hole surgery. Am J Ophthalmol 137: 386; author reply 386-387.
53. Burk SE, Da Mata AP, Snyder ME, Rosa RH Jr, Foster RE, (2000) Indocyanine green-assisted peeling of the retinal internal limiting membrane. Ophthalmology 107: 2010-2014.
54. Penha FM, Maia M, Eid Farah M, Principe AH, Freymuller EH, et al. (2007) Effects of subretinal injections of indocyanine green, trypan blue, and glucose in rabbit eyes. Ophthalmology 114: 899-908.
55. Gale JS, Proulx AA, Gonder JR, Mao AJ, Hutnik CM, (2004) Comparison of the in vitro toxicity of indocyanine green to that of trypan blue in human retinal pigment epithelium cell cultures. Am J Ophthalmol 138: 64-69.
56. Rodrigues EB, Meyer CH, Mennel S, Farah ME, (2007) Mechanisms of intravitreal toxicity of indocyanine green dye: implications for chromovitrectomy. Retina 27: 958-970.
57. Haritoglou C, Ehrt O, Gass CA, Kristin N, Kampik A, (2001) Paracentral scotomata: a new finding after vitrectomy for idiopathic macular hole. Br J Ophthalmol 85: 231-233.
58. Miura M, Elsner AE, Osako M, Iwasaki T, Okano T, et al. (2003) Dissociated optic nerve fiber layer appearance after internal limiting membrane peeling for idiopathic macular hole. Retina 23: 561-563.
59. Welch JC, (1997) Dehydration injury as a possible cause of visual field defect after pars plana vitrectomy for macular hole. Am J Ophthalmol 124: 698-699.
60. Yamashita T, Uemura A, Kita H, Sakamoto T, (2006) Analysis of the retinal nerve fiber layer after indocyanine green-assisted vitrectomy for idiopathic macular holes. Ophthalmology 113: 280-284.
61. Stalmans P, Van Aken EH, Veckeneer M, Feron EJ, Stalmans I, (2002) Toxic effect of indocyanine green on retinal pigment epithelium related to osmotic effects of the solvent. Am J Ophthalmol 134: 282-285.
62. Jackson TL, Hillenkamp J, Knight BC, Zhang JJ, Thomas D, et al. (2004) Safety testing of indocyanine green and trypan blue using retinal pigment epithelium and glial cell cultures. Invest Ophthalmol Vis Sci 45: 2778-2785.
63. Gandorfer A, Haritoglou C, Kampik A, (2003) Retinal damage from indocyanine green in experimental macular surgery. Invest Ophthalmol Vis Sci 44: 316-323.
64. Haritoglou C, Gandorfer A, Gass CA, Kampik A, (2004) Histology of the vitreoretinal interface after staining of the internal limiting membrane using glucose 5% diluted indocyanine and infracyanine green. Am J Ophthalmol 137: 345-348.
65. Haritoglou C, Gandorfer A, Schaumberger M, Tadayoni R, Kampik A, (2003) Light-absorbing properties and osmolarity of indocyanine-green depending on concentration and solvent medium. Invest Ophthalmol Vis Sci 44: 2722-2729.